Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Eur Neuropsychopharmacol. 2015 Dec 10;26(2):186–194. doi: 10.1016/j.euroneuro.2015.12.022

Fig. 1.

Fig. 1

Subchronic administration of ceftriaxone attenuates context-primed relapse after abstinence (A) Mean infusions during the self-administration period did not differ between groups later given VEH or CEF. (B) CEF treatment significantly decreased responding on the previously active lever while having no effect on inactive lever presses during the relapse test. (n=6–8/group). Error bars depict the SEM.